Physician Assistant in Walnut Creek, CA Accepting Medicare
106 Physician Assistant nurses found. Showing 101 - 106
 Heidi Heal, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 370 N. Wiget Lane, Suite 210, Walnut Creek, CA 94598 Phone: 925-935-6252 Fax: 925-935-7611 |
Megan Smith, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2625 Shadelands Dr, Walnut Creek, CA 94598 Phone: 925-939-8585 |
Alice Nelly Bolick, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 450 N Wiget Ln, Walnut Creek, CA 94598 Phone: 925-691-9806 |
Danielle Bohan, PA-C Physician Assistant - Surgical Medicare: Medicare Enrolled Practice Location: 2625 Shadelands Dr, Walnut Creek, CA 94598 Phone: 925-939-8585 |
Elaine Rotha Lim, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 355 Lennon Ln Ste 255, Walnut Creek, CA 94598 Phone: 925-932-7704 Fax: 925-932-7752 |
Claire Elizabeth Kerney, PA-C Physician Assistant - Surgical Medicare: Medicare Enrolled Practice Location: 1425 S Main St, Walnut Creek, CA 94596 Phone: 925-295-4130 |
News Archive
Mayo Clinic researchers estimate lifetime risk of developing rheumatoid arthritis in men and women
Mayo Clinic researchers have determined the lifetime risk of developing rheumatoid arthritis and six other autoimmune rheumatic diseases for both men and women. The findings appear online in Arthritis and Rheumatism.
Inhaled prostacyclin improves oxygenation in acute respiratory distress syndrome patients
The findings reveal that inhaled prostacyclin significantly improves oxygenation in ARDS patients who had COVID-19. The study is currently available on the medRxiv* preprint server.
Positive results from phase 2 trial of Telintra, drug candidate in myelodysplastic syndrome
Telik, Inc. reported positive interim data from a Phase 2 trial of its Telintra (TLK199) drug candidate in myelodysplastic syndrome (MDS). The data were reported in two presentations at the annual meeting of the American Society of Hematology in San Diego.
New HIV drug on the block
Johnson and Johnson's experimental HIV drug rilpivirine or TMC278, a non-nucleoside reverse transcriptase inhibitor (NNRTI), is being developed for use in combination therapy for treating the human immunodeficiency virus (HIV) that causes AIDS. Two clinical trials with the drug has shown that although its effectiveness was same as the existing anti-HIV drugs, its side effects were fewer. On the flip side nearly twice as many patients failed to respond to treatment with the new drug.
Pilot program made first-year medical students more sensitive to older people
Creating art with older "teammates" made first-year medical students more sensitive to older people, according to results of the Vital Visionaries Collaboration (VV), a pilot program developed by the National Institute on Aging in conjunction with the Johns Hopkins School of Medicine and the American Visionary Art Museum in Baltimore, MD.
› Verified 3 days ago